Immunity to influenza A H9N2 viruses induced by infection and vaccination.
about
Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human populationGenetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 Avian Influenza virusesPathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cellsSafety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.Serological and virological surveillance of avian influenza A virus H9N2 subtype in humans and poultry in Shanghai, China, between 2008 and 2010The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA.Animal models in influenza vaccine testing.Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.The viral nucleoprotein determines Mx sensitivity of influenza A viruses.Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccineH5N1 pathogenesis studies in mammalian models.Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat.Protection against lethal influenza virus challenge by RNA interference in vivo.Origin and characteristics of internal genes affect infectivity of the novel avian-origin influenza A (H7N9) virus.Emerging respiratory viruses: challenges and vaccine strategiesVirus aggregating peptide enhances the cell-mediated response to influenza virus vaccineVaccination against H9N2 avian influenza virus reduces bronchus-associated lymphoid tissue formation in cynomolgus macaques after intranasal virus challenge infection.DNA aptamers against the receptor binding region of hemagglutinin prevent avian influenza viral infection.MiR674 inhibits the neuraminidase-stimulated immune response on dendritic cells via down-regulated Mbnl3.Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay.
P2860
Q21245109-DD403539-0C26-49B7-B4B7-C48009AB786CQ27322724-82D29028-94B9-4D94-8697-835BD65810BBQ30339011-409C53E9-46CB-4390-A69A-8E36B9518DBFQ30357092-844F7591-426E-4C8F-B525-3B07C7AF3C10Q30357294-6B8995DF-9A20-457A-98E7-7D2138BF94F7Q30362291-4BB72308-BE57-4545-BBD7-7B90B9EADFFAQ30369723-B0BFC486-51D4-4ADD-8A72-C9B355D067B7Q30371058-E2347B33-BE69-4033-99D4-8538CC6251CBQ30375784-1024BDE4-C58A-4832-A2C7-1D9CFDA92C9DQ30387829-D2E67996-061B-4025-B326-948971E0E37FQ30403933-EFC16CBE-1D0C-45FD-AC9B-E99F9274E69BQ30406344-176D5305-9BB4-4234-8BC6-C2D236AAB2F7Q30427806-881E7060-7CB5-497F-B4AA-D2027FA6D1D0Q34339592-2BCD87FF-6E71-4997-A493-4F15A6681C19Q34514565-00C13850-D950-431E-984F-D39900C3735AQ35053916-5707044F-79E4-4991-9861-F26A420C18A7Q35070868-17C25A02-20A6-4F3D-9B5F-4053C268E8CFQ35301495-514B4D4A-975A-4966-9059-9901511CE6FDQ36210996-9BA5E8B3-9B43-4224-95E0-12BB61CDF57DQ37461328-031E9A69-5A3A-425A-BDC4-56E6EA192C7FQ37580153-73E5C899-6E1D-40A9-A0FA-63268F42523EQ40689515-8C580367-3A5B-4E34-8084-92DA2A4A1B6B
P2860
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@ast
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@en
type
label
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@ast
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@en
prefLabel
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@ast
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@en
P2093
P2860
P1433
P1476
Immunity to influenza A H9N2 viruses induced by infection and vaccination.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.10.4896-4901.2001
P577
2001-05-01T00:00:00Z